CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burjorjee, J. E.
Right arrow Articles by Milne, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burjorjee, J. E.
Right arrow Articles by Milne, B.
Canadian Journal of Anesthesia 49:973-977 (2002)
© Canadian Anesthesiologists' Society, 2002

Cardiothoracic Anesthesia, Respiration and Airway

Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol

[Le propofol et la tempête électrique; l’observation d’un cas de cardioversion et de suppression de la tachycardie ventriculaire par le propofol]

Jessica E. Burjorjee, MD and Brian Milne, FRCP(C)

From the Department of Anaesthesiology, Queen’s University, Kingston, Ontario, Canada.

Address correspondence to: Dr. Brian Milne, Department of Anaesthesiology, Victory 2, Kingston General Hospital, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada. Phone: 613-548-3232 ext. 7827; E-mail: milneb{at}post.queensu.ca

Purpose: To present a case report where propofol abolished recurrent ventricular tachycardia (VT) and to suggest a mechanism by which this may have occurred.

Clinical features: A 65-yr-old male was admitted to the intensive care unit (ICU) with electrical storm. Recurrent episodes of VT persisted despite maximal anti-arrhythmic therapy and resulted in a prolonged ICU course and the need for intra-aortic balloon pump support. This was complicated by an ischemic limb, necessitating an anesthetic for femoral thrombectomy. On several occasions while in the ICU, episodes of VT had resolved with boluses of propofol prior to planned cardioversion. In the operating room, episodes of non-sustained VT resolved after a bolus of propofol and remained suppressed for the duration of the case with the use of a propofol infusion.

Conclusion: The effects of propofol on cardiac conduction and on the autonomic nervous system have been studied but its effects on arrhythmias are not well documented. In this case report, propofol was associated with the resolution and suppression of VT. Recent evidence suggests that sympathetic blockade may be an effective treatment for electrical storm. This may be the mechanism by which propofol can abolish this arrhythmia intraoperatively.




This article has been cited by other articles:


Home page
JAMAHome page
A. K. Gehi, D. Mehta, and J. A. Gomes
Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock
JAMA, December 20, 2006; 296(23): 2839 - 2847.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
S. King and D. Banker
Etomidate as an antiarrhythmic
Br. J. Anaesth., September 1, 2005; 95(3): 425 - 425.
[Full Text] [PDF]


Home page
EuropaceHome page
L.J. Jordaens and J.M. Mekel
Electrical storm in the ICD era
Europace, January 1, 2005; 7(2): 181 - 183.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaballos, J. Almendral, M. J. Anadon, P. Gonzalez, and J. Navia
Comparative effects of thiopental and propofol on atrial vulnerability: electrophysiological study in a porcine model including acute alcoholic intoxication
Br. J. Anaesth., September 1, 2004; 93(3): 414 - 421.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Canadian Anesthesiologists' Society.